ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
SAB Biotherapeutics Inc

SAB Biotherapeutics Inc (SABS)

2.80
-0.06
(-2.10%)
Closed 28 July 6:00AM
2.80
0.00
(0.00%)
After Hours: 8:41AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 6.35M3.59M2.16M581k86k1.27M305k945k
Operating Income -6.54M-7.81M-7.86M-7.4M-6.48M-5.32M-18.87M-11.39M
Pre Tax Income -4.87M-7.08M-7.85M-7.35M-6.88M-5.1M-22.86M-5.03M
Net Income -4.78M-7.08M-7.88M-7.35M-6.88M-5.1M-22.86M-5.03M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -6.54M-7.81M-7.83M-7.4M-6.48M-5.23M-18.54M-10.92M
EBITDA -5.79M-6.92M-6.96M-6.51M-5.61M-4.36M-17.95M-9.43M
Year End 31 December 2023 2020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 060.88M23.9M2.24M
Operating Income -9k-13.39M-28.92M-38.08M
Pre Tax Income -9k-17.15M-18.72M-42.19M
Net Income -9k-17.15M-18.74M-42.19M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.003-0.394-0.436-0.806
EBIT -9k-13.39M-28.88M-37.64M
EBITDA -9k-11.91M-25.75M-34.42M

Your Recent History

Delayed Upgrade Clock